Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4167 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Statin evaluated as heart failure preventative

While statins are used primarily to lower cholesterol levels, there is evidence that these drugs may also have beneficial effects on blood vessel function independent of cholesterol levels.

Acadia drug looks safe in schizophrenia

ACP-104 is currently being evaluated in three clinical trials, all of which are being conducted in patients with schizophrenia. The first clinical trial is a placebo-controlled, single ascending-dose

Sleeping pills pose risks to older users

Insomnia can often affect the quality of life for older people leading many to rely on commonly used tranquilizers such as benzodiazepines, known to be highly addictive. The

Researchers grow stem cells from adults

Human stem cells offer tremendous hope for the development of revolutionary medical treatments for a variety of human health problems including damaged muscle tissue, bone injuries and nerve

Cat litter linked to mental illness

Dr Fuller Torrey, president of the Stanley Medical Research Institute in Bethesda, has found that the parasite known as Toxoplasma gondii, often found in cat droppings, can produce

King buys rights to Pain Therapeutics drug

Remoxy is an investigational drug in late-stage clinical development by Pain Therapeutics for the treatment of moderate-to-severe chronic pain. Under the terms of the agreement, King will make